Involvement of eosinophils in the anti-tumor response

Cancer Immunology, Immunotherapy

Volumn 61, Issue 9, 2012, Pages 1527-1534

  Gatault, Solène ^a   Legrand, Fanny ^a,b   Delbeke, Marie ^a   Loiseau, Sylvie ^a   Capron, Monique ^a  

^a UNIV LILLE   (France)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AllergoOncology Symposium in Writing; Cytotoxicity; Eosinophils; Tumors

Indexed keywords

EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 17E; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 25; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ACTIVITY; CELL INFILTRATION; CELL MIGRATION; COLON CANCER; CONFERENCE PAPER; CYTOKINE RELEASE; CYTOTOXICITY; DISEASE ASSOCIATION; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; KIDNEY CARCINOMA; LUNG CANCER; MELANOMA; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR ASSOCIATED TISSUE EOSINOPHILIA;

ADAPTIVE IMMUNITY; ANIMALS; EOSINOPHILS; HUMANS; IMMUNITY, INNATE; NEOPLASMS;

EID: 84866545747     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1288-3     Document Type: Conference Paper

References (54)

1. Munitz A, Levi-SchaVer F (2004) Eosinophils: 'new' roles for 'old' cells. Allergy 59(3):268-275 (Pubitemid 38339842)
2. Lowe D, Jorizzo J, Hutt MS (1981) Tumour-associated eosinophilia: a review. J Clin Pathol 34(12):1343-1348 (Pubitemid 12168683)
3. Kita H (2011) Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 242(1):161-177
4. Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, Kremer L, Adam E, Woerly G, Dombrowicz D, Capron M (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113(14):3235-3244
5. Legrand F, Driss V, Delbeke M, Loiseau S, Hermann E, Dombrowicz D, Capron M (2010) Human eosinophils exert TNF-alpha and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol 185(12):7443-7451
6. Legrand F, Driss V, Woerly G, Loiseau S, Hermann E, Fournie JJ, Heliot L, Mattot V, Soncin F, Gougeon ML, Dombrowicz D, Capron M (2009) A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils. PLoS ONE 4(6):e5926
7. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, Moretta L, Colonna M, Levi-SchaVer F (2005) 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 174(1):110-118 (Pubitemid 40007397)
8. Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147-174
9. Gleich GJ (2000) Mechanisms of eosinophil-associated inXammation. J Allergy Clin Immunol 105(4):651-663
10. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5):709-750 (Pubitemid 351550670)
11. Abu-Ghazaleh RI, Gleich GJ, Prendergast FG (1992) Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity. J Membr Biol 128(2):153-164
12. Lucey DR, Nicholson-Weller A, Weller PF (1989) Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 86(4):1348-1351 (Pubitemid 19061543)
13. Spencer LA, Weller PF (2010) Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol 88(3):250-256
14. Yang D, Chen Q, Su SB, Zhang P, Kurosaka K, Caspi RR, Michalek SM, Rosenberg HF, Zhang N, Oppenheim JJ (2008) Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 205(1):79-90 (Pubitemid 351185717)
15. Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA (2010) Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy 40(4):563-575
16. Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG II, Kimball PM, Boohaker EA (1983) Eosinophil inWltration of human colonic carcinomas as a prognostic indicator. Cancer Res 43(6):2997-3000 (Pubitemid 13100579)
17. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A (2000) Prognostic inXuence of tumor-associated eosinophilic inWltrate in colorectal carcinoma. Cancer 88(7):1544-1548 (Pubitemid 30183138)
18. Dorta RG, Landman G, Kowalski LP, Lauris JR, Latorre MR, Oliveira DT (2002) Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 41(2):152-157 (Pubitemid 34985188)
19. Ishibashi S, Ohashi Y, Suzuki T, Miyazaki S, Moriya T, Satomi S, Sasano H (2006) Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res 26(2B): 1419-1424
20. Fujii M, Yamashita T, Ishiguro R, Tashiro M, Kameyama K (2002) SigniWcance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29(2):175-181 (Pubitemid 34230369)
21. Ono Y, Ozawa M, Tamura Y, Suzuki T, Suzuki K, Kurokawa K, Fukabori Y, Yamanaka H (2002) Tumor-associated tissue eosinophilia of penile cancer. Int J Urol 9(2):82-87 (Pubitemid 34299174)
22. Costello R, O'Callaghan T, Sebahoun G (2005) Eosinophils and antitumour response. Rev Med Interne 26(6):479-484 (Pubitemid 40779663)
23. Luna-More S, Florez P, Ayala A, Diaz F, Santos A (1997) Neutral and acid mucins and eosinophil and argyrophil crystalloids in carcinoma and atypical adenomatous hyperplasia of the prostate. Pathol Res Pract 193(4):291-298 (Pubitemid 27399703)
24. von Wasielewski R, Seth S, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A (2000) Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 95(4):1207-1213 (Pubitemid 30099828)
25. Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Improta S, Juzbasic S, Todesco M, Perin V, Gattei V, Herrmann F, Gruss HJ, Carbone A (1996) Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 88(9):3299-3305 (Pubitemid 26365562)
26. Geisinger KR, SteVee CH, McGee RS, WoodruV RD, Buss DH (1998) The cytomorphologic features of sclerosing mucoepidermoid carcinoma of the thyroid gland with eosinophilia. Am J Clin Pathol 109(3):294-301 (Pubitemid 28110571)
27. Fridlender ZG, Simon HU, Shalit M (2003) Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism. Am J Med Sci 326(2):98-101 (Pubitemid 36993116)
28. Dibbert B, Daigle I, Braun D, Schranz C, Weber M, Blaser K, Zangemeister-Wittke U, Akbar AN, Simon HU (1998) Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocytemacrophage colony-stimulating factor and interleukin-5. Blood 92(3):778-783 (Pubitemid 28355459)
29. Teruya-Feldstein J, JaVe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G (1999) DiVerential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93(8):2463-2470 (Pubitemid 29181176)
30. Lorena SC, Oliveira DT, Dorta RG, Landman G, Kowalski LP (2003) Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. Oral Dis 9(6):279-283 (Pubitemid 37420489)
31. Thielen C, Radermacher V, Trimeche M, Roufosse F, Goldman M, Boniver J, de Leval L (2008) TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 32(9):1431-1438
32. Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, Dimina D, Ochkur SI, O'Neill K, Colbert D, Lombari TR, Constant S, McGarry MP, Lee JJ, Lee NA (2006) Pivotal advance: eosinophil inWltration of solid tumors is an early and persistent in-Xammatory host response. J Leukoc Biol 79(6):1131-1139 (Pubitemid 44835546)
33. Stenfeldt AL, Wenneras C (2004) Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112(4):605-614 (Pubitemid 39061486)
34. LotW R, Lee JJ, Lotze MT (2007) Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inXammatory response within tumors. J Immunother 30(1):16-28 (Pubitemid 46052200)
35. Ito N, DeMarco RA, Mailliard RB, Han J, Rabinowich H, Kalinski P, Stolz DB, Zeh HJ III, Lotze MT (2007) Cytolytic cells induce HMGB1 release from melanoma cell lines. J Leukoc Biol 81(1): 75-83 (Pubitemid 46021255)
36. LotW R, Herzog GI, DeMarco RA, Beer-Stolz D, Lee JJ, Rubartelli A, Schrezenmeier H, Lotze MT (2009) Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol 183(8):5023-5031
37. Sun P, Ben Q, Tu S, Dong W, Qi X, Wu Y (2011) Serum interleukin-33 levels in patients with gastric cancer. Dig Dis Sci 56(12): 3596-3601
38. Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, Kouro T, Itakura A, Nagai Y, Takaki S, Takatsu K (2011) IdentiWcation of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 188(2):703-713
39. Caruso RA, Parisi A, Quattrocchi E, Scardigno M, Branca G, Parisi C, Luciano R, Paparo D, Fedele F (2011) Ultrastructural descriptions of heterotypic aggregation between eosinophils and tumor cells in human gastric carcinomas. Ultrastruct Pathol 35(4):145-149
40. Huland E, Huland H (1992) Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol 118(6):463-467
41. Simon HU, Plotz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-SchaVer F (2003) Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Eur J Immunol 33(4):834-839 (Pubitemid 36546670)
42. Sosman JA, Bartemes K, OVord KP, Kita H, Fisher SG, Kefer C, Ellis TA, Fisher RI, Higgins TJ, Gleich GJ (1995) Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: eVects of interleukin-4 alone and following interleukin-2 administration. Clin Cancer Res 1(8):805-812
43. Tepper RI, CoVman RL, Leder P (1992) An eosinophil-dependent mechanism for the antitumor eVect of interleukin-4. Science 257(5069):548-551
44. Rivoltini L, Viggiano V, Spinazze S, Santoro A, Colombo MP, Takatsu K, Parmiani G (1993) In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Int J Cancer 54(1):8-15 (Pubitemid 23136992)
45. Benatar T, Cao MY, Lee Y, Lightfoot J, Feng N, Gu X, Lee V, Jin H, Wang M, Wright JA, Young AH (2010) IL-17E, a proinXammatory cytokine, has antitumor eYcacy against several tumor types in vivo. Cancer Immunol Immunother 59(6):805-817
46. Mattes J, Hulett M, Xie W, Hogan S, Rothenberg ME, Foster P, Parish C (2003) Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 197(3):387-393 (Pubitemid 36184245)
47. Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, Smyth MJ, Parish CR (2007) Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol 178(7):4222-4229 (Pubitemid 46492372)
48. Turner MC, Chen Y, Krewski D, Ghadirian P (2006) An overview of the association between allergy and cancer. Int J Cancer 118(12):3124-3132
49. Wang H, Diepgen TL (2005) Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 60(9):1098-1111 (Pubitemid 41153134)
50. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodriguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H (2008) AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63(10):1255-1266
51. Tomassini M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L, Capron A, Capron M (1991) Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol 88(3 Pt 1):365-375
52. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M (1994) High-aYnity IgE receptor on eosinophils is involved in defence against parasites. Nature 367(6459):183-186 (Pubitemid 24031700)
53. Jonsson UB, Bystrom J, Stalenheim G, Venge P (2002) Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms. Clin Exp Allergy 32(7):1092-1095 (Pubitemid 34779608)
54. Molin D (2004) Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis. Ups J Med Sci 109(3):179-228 (Pubitemid 39345454)